1310555-00-0

Basic information

• Product Name: (3aS,4S,5R,6R,7S,7ar)-4,5,6,7-tetrakis(benzyloxy)-hexahydro-1H-benzo[d]imidazol-2(3H)-one
• CAS NO: 1310555-00-0
• Molecular Weight: 564.681
• Mol File: 1310555-00-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (3aS,4S,5R,6R,7S,7ar)-4,5,6,7-tetrakis(benzyloxy)-hexahydro-1H-benzo[d]imidazol-2(3H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: (3aS,4S,5R,6R,7S,7ar)-4,5,6,7-tetrakis(benzyloxy)-hexahydro-1H-benzo[d]imidazol-2(3H)-one(1310555-00-0)
• EPA Substance Registry System: (3aS,4S,5R,6R,7S,7ar)-4,5,6,7-tetrakis(benzyloxy)-hexahydro-1H-benzo[d]imidazol-2(3H)-one(1310555-00-0)

Safety Data

• Hazardous Substances Data: 1310555-00-0(Hazardous Substances Data)

Upstream product

• 898831-70-4 ((1S,2R,3R,4S,5R,6S)-5,6-diazidocyclohexane-1,2,3,4-tetrayl)tetrakis(oxy)tetrakis(methylene)tetrabenzene 
• 530-62-1 1,1'-carbonyldiimidazole 
• 110550-27-1 (1S,2R,3R,4S)-cyclohex-5-ene-1,2,3,4-tetrayltetrakis(oxy)tetrakis(methylene)tetrabenzene 
• 100-39-0 benzyl bromide 
• 138258-55-6 (1S,2R,3R,4S)-1,2,3,4,tetrahydroxy-5-cyclohexene 
• 24558-77-8 3,4,5,6-tetra-O-benzyl inositol 

Relevant articles and documents

The myo-1,2-diaminocyclitol scaffold defines potent glucocerebrosidase activators and promising pharmacological chaperones for gaucher disease

A series of cyclitol derivatives with myo-configuration are β-glucocerebrosidase (GCase) inhibitors and show excellent characteristics for the development of pharmacological chaperones for enzyme deficiency in Gaucher disease (GD). The most potent inhibit